Nasus Pharma Ltd.
NSRX | AMEX
$3.16
-$0.15 (-4.53%)
At close: Oct 30, 2026, 3:59 PM ET
$3.16
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 3:59 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a |
Operating Income | -4.9M | -1.08M | -1.15M | -2.04M |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | -5.81M | -1.55M | -1.01M | -2.15M |
Net Income | -5.86M | -1.53M | -1.05M | -1.71M |
Selling & General & Admin | 2.67M | 743K | 580K | 926K |
Research & Development | 2.24M | 335K | 567K | 1.12M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 4.9M | 1.08M | 1.15M | 2.04M |
Interest Expense | n/a | 29K | 49K | 18K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.9M | 1.08M | 1.15M | 2.04M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 8.01M | 9.06M | 9.06M | 9.06M |
Shares Outstanding (Diluted) | 8.01M | 9.06M | 9.06M | 9.06M |
EPS (Basic) | -0.72 | -0.17 | -0.12 | -0.19 |
EPS (Diluted) | -0.72 | -0.17 | -0.12 | -0.19 |
EBITDA | -4.9M | -1.52M | -956K | -2.13M |
EBIT | -4.9M | -1.52M | -956K | -2.13M |
Depreciation & Amortization | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NSRX